Y-27632 dihydrochloride: Selective ROCK Inhibitor for Rho/ROCK Pathway Research

Executive Summary: Y-27632 dihydrochloride is a potent and selective inhibitor of Rho-associated protein kinases ROCK1 and ROCK2 (IC₅₀ 140 nM, Ki 300 nM) with >200-fold selectivity over other kinases. It disrupts Rho-mediated stress fiber formation, modulates G1/S cell cycle progression, and inhibits cytokinesis in vitro [1]. Y-27632 dihydrochloride is highly soluble in DMSO (≥111.2 mg/mL), ethanol, and water under defined conditions and remains stable for months when stored at -20°C. Research demonstrates its utility in reducing tumor invasion and enhancing stem cell viability, making it a standard tool for probing Rho/ROCK signaling [product].

Biological Rationale

The Rho/ROCK signaling pathway orchestrates cytoskeletal dynamics, cell adhesion, motility, and cell cycle progression. ROCK1 and ROCK2 are serine/threonine kinases activated by RhoA-GTP binding. Their activity modulates actomyosin contractility, stress fiber formation, and tight junction stability. Dysregulation of ROCK signaling is linked to tumor progression, metastasis, and impaired stem cell survival [1]. Inhibiting ROCK kinases is a validated approach to dissecting cytoskeletal organization, cell proliferation, and tissue regeneration mechanisms. Y-27632 dihydrochloride provides a highly selective, reversible, and cell-permeable means to block ROCK1/2 activity without substantially affecting related kinases. This specificity facilitates mechanistic studies in cancer biology, stem cell research, and virology.

Mechanism of Action of Y-27632 dihydrochloride

Y-27632 dihydrochloride competes with ATP at the catalytic domain of ROCK1 and ROCK2. The compound inhibits ROCK1 with an IC₅₀ of ~140 nM and ROCK2 with a Ki of 300 nM [product]. Selectivity is >200-fold relative to PKC, cAMP-dependent protein kinase, MLCK, and PAK. Inhibition of ROCK disrupts phosphorylation of downstream targets, including myosin light chain 2 (MLC2), leading to decreased actomyosin contractility and stress fiber formation. In cellular models, Y-27632 dihydrochloride blocks RhoA/ROCK1/MLC2 signaling, stabilizing tight junctions and reducing cell membrane permeability [1]. It also interferes with cell cycle progression from G1 to S phase and impairs cytokinesis, contributing to anti-proliferative effects.

Evidence & Benchmarks

• Y-27632 dihydrochloride inhibits ROCK1 catalytic activity with an IC₅₀ of 140 nM in vitro (ApexBio datasheet, product).
• ROCK2 is inhibited with a Ki of 300 nM, demonstrating high potency (ApexBio, product).
• Compound shows >200-fold selectivity over PKC, cAMP-dependent protein kinase, MLCK, and PAK, minimizing off-target effects (ApexBio, product).
• In canine cell models, specific ROCK1 inhibitors such as Y-27632 dihydrochloride restore tight junction integrity and reduce viral protein expression during Minute Virus of Canines (MVC) infection [1].
• Y-27632 dihydrochloride reduces proliferation of prostatic smooth muscle cells in vitro in a concentration-dependent manner (ApexBio, product).
• In vivo, Y-27632 reduces pathological tumor structures and inhibits metastasis in mouse models (ApexBio, product).

Applications, Limits & Misconceptions

Y-27632 dihydrochloride is applied in studies of:

• Cytoskeletal organization and stress fiber formation inhibition.
• Cell cycle regulation and cytokinesis interference.
• Enhancement of stem cell survival and viability in culture.
• Tumor invasion, metastasis, and cancer migration assays.
• Virology studies involving Rho/ROCK-mediated cell entry, such as MVC infection [1].

This article extends previous coverage (e.g., Y-27632 Dihydrochloride: A Selective ROCK Inhibitor Trans...) by emphasizing quantitative selectivity benchmarks and virology use-cases. It also clarifies distinctions from broader reviews such as Unlocking Translational Potential with Y-27632 Dihydrochl..., focusing on validated, non-hypothetical effects in in vitro and in vivo models.

Common Pitfalls or Misconceptions

• Not a pan-kinase inhibitor: Y-27632 dihydrochloride does not broadly inhibit all kinases; its selectivity for ROCK1/2 is well-defined.
• No direct antiviral effect: It does not neutralize viruses but modulates host cell pathways (e.g., tight junction stabilization in MVC studies).
• Not a growth factor or cell survival agent per se: Its effect on stem cell viability is via ROCK pathway modulation, not direct trophic support.
• Long-term solution storage is discouraged: Activity may decline in solution; prepare fresh aliquots as needed [product].
• Effects are reversible: Removal of Y-27632 dihydrochloride restores ROCK activity, so continuous exposure is required for persistent inhibition.

Workflow Integration & Parameters

Y-27632 dihydrochloride (A3008) is supplied as a solid and should be stored desiccated at 4°C or below. For solution preparation, DMSO (≥111.2 mg/mL), ethanol (≥17.57 mg/mL), or water (≥52.9 mg/mL) are recommended. Warming to 37°C or ultrasonic bath treatment improves solubility. Stock solutions are stable below -20°C for several months; avoid repeated freeze-thaw. For in vitro use, concentrations typically range from 1–10 µM, depending on model system and endpoint. In cell culture, verify absence of cytotoxicity and titrate for optimal effect. For detailed protocols, see the Y-27632 dihydrochloride product page.

For advanced applications in organoid or neural studies, see Y-27632 Dihydrochloride: Precision ROCK Inhibitor for Neu.... This article adds quantitative selectivity and virology benchmarks to extend those neural and organoid-focused workflows.

Conclusion & Outlook

Y-27632 dihydrochloride is a validated, selective, and potent ROCK inhibitor that enables precise modulation of Rho/ROCK signaling in diverse cell models. Its quantitative inhibition profile, high solubility, and benchmarked applications in cytoskeletal and cancer research make it a standard in the field. Future research may expand its use in tissue regeneration and virus-host interaction studies, leveraging its specificity and reversible action. For detailed parameters and ordering, refer to the A3008 kit product page.